Biology subjects

Moult, J.

Publications and source records attributed to Moult, J..

7 recordsLinked to original sources

bioRxiv2025

Modeling Alternative Conformational States in CASP16

The CASP16 Ensemble Prediction experiment assessed advances in methods for modeling proteins, nucleic acids, and their complexes in multiple conformational states. Targets included systems with experimental structures determined in two or three states, evaluated by direct comparison to experimental coordinates, as well as domain-linker-domain (D-L-D) targets assessed against statistical models from NMR and SAXS data. This paper focuses on the former class of multi-state targets. Ten ensembles were released as community challenges, including ligand-induced conformational changes, protein-DNA complexes, a trimeric protein, a stem-loop RNA, and multiple oligomeric states of a single RNA. For five targets, some groups produced reasonably accurate models of both reference states (best TM-score >0.75). However, with the exception of one protein-ligand complex (T1214), where an apo structure was available as a template, predictors generally failed to capture key structural details distinguishing the states. Overall, accuracy was significantly lower than for single-state targets in other CASP experiments. The most successful approaches generated multiple AlphaFold2 models using enhanced multiple sequence alignments and sampling protocols, followed by model quality based selection. While the AlphaFold3 server performed well on several targets, individual groups outperformed it in specific cases. By contrast, predictions for one protein-DNA complex, three RNA targets, and multiple oligomeric RNA states consistently fell short (TM-score <0.75). These results highlight both progress and persistent challenges in multi-state prediction. Despite recent advances, accurate modeling of conformational ensembles, particularly RNA and large multimeric assemblies, remains a critical frontier for structural biology.

biochemistry↗

bioRxiv2025

Functional relevance of CASP16 nucleic acid predictions as evaluated by structure providers

Accurate biomolecular structure prediction enables the prediction of mutational effects, the speculation of function based on predicted structural homology, the analysis of ligand binding modes, experimental model building and many other applications. Such algorithms to predict essential functional and structural features remain out of reach for biomolecular. Here, we report quantitative and qualitative evaluation of nucleic acid structures for the CASP16 blind prediction challenge by 12 of the experimental groups who provided nucleic acid targets. Blind predictions accurately model secondary structure and some aspects of tertiary structure, including reasonable global folds for some complex RNAs, however, predictions often lack accuracy in the regions of highest functional importance. All models have inaccuracies in non-canonical regions where, e.g., the nucleic-acid backbone bends or a base forms a non-standard hydrogen bond. These bends and non-canonical interactions are integral to form functionally important regions such as RNA enzymatic active sites. Additionally, the modeling of conserved and functional interfaces between nucleic acids and ligands, proteins, or other nucleic acids remains poor. For some targets, the experimental structures may not represent the only structure the biomolecular complex occupies in solution or in its functional life-cycle, posing a future challenge for the community.

biophysics↗

bioRxiv2022

Novel Antibody Interfaces Revealed Through Structural Mining

Antibodies are fundamental effectors of humoral immunity, and have become a highly successful class of therapeutics. There is increasing evidence that antibodies utilize transient homotypic interactions to enhance function, and elucidation of such interactions can provide insights into their biology and new opportunities for their optimization as drugs. Yet the transitory nature of weak interactions makes them difficult to investigate. Capitalizing on their rich structural data and high conservation, we have characterized all the ways that antibody Fab regions interact crystallographically. This approach led to the discovery of previously unrealized interfaces between antibodies. While diverse interactions exist, {beta}-sheet dimers and variable-constant elbow dimers are recurrent motifs. Disulfide engineering enabled interactions to be trapped and investigated structurally and functionally, providing experimental validation of the interfaces and illustrating their potential for optimization. This work provides first insight into previously undiscovered oligomeric interactions between antibodies, and enables new opportunities for their biotherapeutic optimization.

biochemistry↗

bioRxiv2020

MecCog: A knowledge representation framework for genetic disease mechanism

MotivationExperimental findings on genetic disease mechanisms are scattered throughout the literature and represented in many ways, including unstructured text, cartoons, pathway diagrams, and network graphs. Integration and structuring of such mechanistic information will greatly enhance its utility. ResultsMecCog is a graphical framework for building integrated representations (mechanism schemas) of mechanisms by which a genetic variant causes a disease phenotype. A MecCog mechanism schema displays the propagation of system perturbations across stages of biological organization, using graphical notations to symbolize perturbed entities and activities, hyperlinked evidence tagging, a mechanism ontology, and depiction of knowledge gaps, ambiguities, and uncertainties. The web platform enables a user to construct, store, publish, browse, query, and comment on schemas. MecCog facilitates the identification of potential biomarkers, therapeutic intervention sites, and critical future experiments. Availability and ImplementationThe MecCog framework is freely available at http://www.meccog.org. Contactjmoult@umd.edu Supplementary informationSupplementary material is available at Bioinformatics online.

systems biology↗

bioRxiv2019

Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype-weighted knowledge in the CAGI SickKids5 clinical genomes challenge

Precise identification of causative variants from whole-genome sequencing data, including both coding and non-coding variants, is challenging. The CAGI5 SickKids clinical genome challenge provided an opportunity to assess our ability to extract such information. Participants in the challenge were required to match each of 24 whole-genome sequences to the correct phenotypic profile and to identify the disease class of each genome. These are all rare disease cases that have resisted genetic diagnosis in a state-of-the-art pipeline. The patients have a range of eye, neurological, and connective-tissue disorders. We used a gene-centric approach to address this problem, assigning each gene a multi-phenotype-matching score. Mutations in the top scoring genes for each phenotype profile were ranked on a six-point scale of pathogenicity probability, resulting in an approximately equal number of top ranked coding and non-coding candidate variants overall. We were able to assign the correct disease class for 12 cases and the correct genome to a clinical profile for five cases. The challenge assessor found genes in three of these five cases as likely appropriate. In the post-submission phase, after careful screening of the genes in the correct genome we identified additional potential diagnostic variants, a high proportion of which are non-coding.

genomics↗

bioRxiv2019

Characterizing and comparing missense variants in monogenic disease and in cancer

In both monogenic disease and cancer a large fraction of causative mutations are missense, even though these are very different types of disease. Here we examine and compare a number of properties of these mutations in the two classes of disease to determine the extent to which the properties of the mutations are similar or different. Analysis of cancer mutations is complicated by the problem of distinguishing between drivers and passengers. After controlling for this factor in three different ways, we find the following: (1) A very high and similar fraction (~90%) of causal mutations in both diseases are at positions under strong selection pressure. (2) Mutations in structurally disordered regions play a minor role in monogenic disease (only about 10% of mutations are in those regions), but a larger role (about 25%) in cancer, largely because of the higher fraction of disordered regions in cancer driver proteins. (3) A large (~75%) and similar fraction of causal mutations in protein cores in both diseases act by significantly destabilizing three-dimensional structure, implying a large impact on protein function. (4) Cancer oncogene mutations tend to be on the protein surface whereas tumor suppressor and monogenic disease mutations are more common in the core. (5) A surprisingly high fraction (~50%) of mutations in cancer passenger genes are at positions under strong selection pressure.

genomics↗

bioRxiv2018

Harnessing formal concepts of biological mechanism to analyze human disease

Mechanism is a widely used concept in biology: in 2017 more than 10% of PubMed abstracts used the term. Thus, searching for and reasoning about mechanisms is fundamental to much of biomedical research, but until now there has been almost no computational infrastructure for this purpose. Recent work in the philosophy of science has explored the central role that the search for mechanistic accounts of biological phenomena plays in biomedical research, providing a conceptual basis for representing and analyzing biological mechanism. The foundational categories for components of mechanisms - entities and activities - guide the development of general, abstract types of biological mechanism parts. Building on that analysis, we have developed a formal framework for describing and representing biological mechanism, MecCog, and applied it to describing mechanisms underlying human genetic disease. Mechanisms are depicted using a graphical notation. Key features are assignment of mechanism components to stages of biological organization and classes; visual representation of uncertainty, ignorance, and ambiguity; and tight integration with literature sources. The MecCog framework facilitates analysis of many aspects of disease mechanism, including the prioritization of future experiments, probing of gene-drug and gene-environment interactions, identification of possible new drug targets, personalized drug choice, analysis of non-linear interactions between relevant genetic loci, and classification of disease based on mechanism.

systems biology↗